Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst ...

Medical device company Globus Medical (NYSE:GMED) fell short of the market’s revenue expectations in Q1 CY2025, with sales ...

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with ...

Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. (“Globus” or the “Company”) (NYSE: GMED). Such investors are ...

Trevor Friedeberg will serve as the new president and CEO of GMED effective June 2, according to a release from the organization. His appointment follows the departure of former President and CEO ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Globus Medical, Inc. 59.16 -0.03% Summary News Chart Statistics Historical data Profile Financials Analysis Options Holders Sustainability NYSE - Delayed Quote • USD Globus Medical, Inc. (GMED) Follow ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “neutral” rating restated by analysts at BTIG Research in a research report issued on Tuesday, Marketbeat Ratings reports.

In a report released today, Ryan Zimmerman from BTIG downgraded Globus Medical to Hold, with a price target of $77.00. The company’s shares closed last Friday at $58.96. According to TipRanks ...

On Tuesday, BTIG analyst Ryan Zimmerman downgraded Globus Medical shares (NYSE:GMED) from Buy to Neutral, citing concerns following the company’s first-quarter results for 2025. According to ...